Capital Expenditures - MaxCyte Inc (NASDAQ:MXCT) - Alpha Spread
M

MaxCyte Inc
NASDAQ:MXCT

Watchlist Manager
MaxCyte Inc
NASDAQ:MXCT
Watchlist
Price: 4.06 USD -0.98%
Market Cap: 425.6m USD
Have any thoughts about
MaxCyte Inc?
Write Note

MaxCyte Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MaxCyte Inc
Capital Expenditures Peer Comparison

Comparables:
TMO
DHR
MTD
A
IQV

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
M
MaxCyte Inc
NASDAQ:MXCT
Capital Expenditures
-$3.7m
CAGR 3-Years
-21%
CAGR 5-Years
-39%
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Capital Expenditures
-$1.4B
CAGR 3-Years
13%
CAGR 5-Years
-10%
CAGR 10-Years
-15%
Danaher Corp
NYSE:DHR
Capital Expenditures
-$1.3B
CAGR 3-Years
-8%
CAGR 5-Years
-14%
CAGR 10-Years
-9%
Mettler-Toledo International Inc
NYSE:MTD
Capital Expenditures
-$94.6m
CAGR 3-Years
3%
CAGR 5-Years
6%
CAGR 10-Years
-1%
Agilent Technologies Inc
NYSE:A
Capital Expenditures
-$369m
CAGR 3-Years
-34%
CAGR 5-Years
-18%
CAGR 10-Years
-7%
IQVIA Holdings Inc
NYSE:IQV
Capital Expenditures
-$613m
CAGR 3-Years
1%
CAGR 5-Years
-2%
CAGR 10-Years
-25%

See Also

What is MaxCyte Inc's Capital Expenditures?
Capital Expenditures
-3.7m USD

Based on the financial report for Dec 31, 2023, MaxCyte Inc's Capital Expenditures amounts to -3.7m USD.

What is MaxCyte Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
-39%

Over the last year, the Capital Expenditures growth was 80%. The average annual Capital Expenditures growth rates for MaxCyte Inc have been -21% over the past three years , -39% over the past five years .

Back to Top